1. Home
  2. CDW vs ELAN Comparison

CDW vs ELAN Comparison

Compare CDW & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CDW Corporation

CDW

CDW Corporation

HOLD

Current Price

$136.94

Market Cap

15.2B

ML Signal

HOLD

Logo Elanco Animal Health Incorporated

ELAN

Elanco Animal Health Incorporated

HOLD

Current Price

$23.57

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDW
ELAN
Founded
1984
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2B
12.7B
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
CDW
ELAN
Price
$136.94
$23.57
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$164.88
$27.89
AVG Volume (30 Days)
1.3M
4.3M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.88%
N/A
EPS Growth
1.38
N/A
EPS
8.08
N/A
Revenue
$10,768,600,000.00
$4,715,000,000.00
Revenue This Year
$4.08
$8.21
Revenue Next Year
$4.01
$5.31
P/E Ratio
$16.57
N/A
Revenue Growth
6.32
6.22
52 Week Low
$112.98
$8.59
52 Week High
$189.45
$27.72

Technical Indicators

Market Signals
Indicator
CDW
ELAN
Relative Strength Index (RSI) 72.83 48.86
Support Level $137.08 $22.17
Resistance Level $150.48 $23.70
Average True Range (ATR) 3.20 0.90
MACD 1.53 0.05
Stochastic Oscillator 100.00 63.87

Price Performance

Historical Comparison
CDW
ELAN

About CDW CDW Corporation

CDW Corp is a multi-brand provider of information technology (IT) solutions to businesses, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's offerings range from hardware and software products to integrated IT solutions and services, including on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. Its reportable segments are Corporate, Small Business, Public, and Other. The Corporate and Small Business segments serve US private sector business customers, while the Public segment consists of government agencies and education and healthcare institutions in the US. The Corporate segment generates the majority of its revenue in the United States.

About ELAN Elanco Animal Health Incorporated

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Share on Social Networks: